Whales with a lot of money to spend have taken a noticeably bullish stance on Rocket Companies.Looking at options history for Rocket Companies (NYSE: RKT) we detected 18 trades.If we consider the specifics of each trade, it is accurate to state that 61% of the investors opened trades with bullish expectations and 27% with bearish.From the overall spotted trades, 5 are puts, for a total amount of $369,944 and 13, calls, for a total amount of $731,836.What's The Price Target?Based on the trading activity, it ...

临床试验结果 - 公司公布VELA-1和VELA-2三期试验第16周结果 主要终点采用HiSCR75标准（脓肿和炎性结节计数减少75%且无新增脓肿或引流隧道）[1] - 试验共纳入838名患者 设计采用120mg剂量sonelokimab与安慰剂对照 第16周读取HiSCR75数据[2] - 所有关键终点均达到统计学显著性 p值小于0.001 包括病灶计数和患者报告结局[3] - 第16周时VELA-1试验组HiSCR75应答率为34.8% VELA-2试验组为35.9%[5] - 安慰剂组应答率VELA-1为17.5%（符合历史三期试验13%-18%范围） VELA-2为25.6%（高于预期）[5] 药物疗效表现 - sonelokimab在第4周就显示出统计学显著的HiSCR75应答[3] - 初步分析显示16周后应答持续改善 安慰剂组交叉给药后在20周达到与初始试验组相似应答水平[4] - 两个试验均实现所有关键次要终点的统计学显著性 包括HiSCR50和IHS4-55等病灶计数指标[6] - 约30%患者在两项试验中实现疼痛显著减轻（最严重疼痛NRS评分改善至少3分）[6] - 近60%患者实现DLQI有临床意义的改善（4分或以上） 较对照组高出约20个百分点[7] 安全性及管理层评价 - 药物安全性良好 与既往研究一致 未出现新的安全信号[7] - 首席科学官表示对VELA-2较高安慰剂应答率感到失望 但对sonelokimab在所有终点的一致性表现感到鼓舞[7] 市场反应 - 公司股价单日暴跌超过90% 报收6.18美元[8]

Detroit Lions rookie wide receiver Isaac Teslaa may not be one of the most recognizable NFL newcomers in 2025, but his one-handed highlight-reel catches are certainly helping. A collaboration with Ford Motor Co (NYSE: F) might help soon, too.F is trading near recent highs. Get the scoop here.What Happened: As a member of the Detroit Lions, Teslaa calls Ford Field home and plays in a league that counts Ford as a sponsor. The automaker took things one step further to make sure that when it comes to electric v ...

Silver is in focus following a scorching rally, and ETFs tied to the metal are making the headlines. The iShares Silver Trust (NYSE: SLV), abrdn Physical Silver Shares ETF (NYSE: SIVR), Global X Silver Miners ETF (NYSE: SIL) and Amplify Junior Silver Miners ETF (NYSE: SILJ) are all being talked about as the metal crosses $46 per ounce, its highest since May 2011. The funds are up 1.9%, 2%, 2.5% and 3.2%, respectively.SLV shares are at critical resistance. Check the full analysis here.SLV and SIVR are still ...

Deep-pocketed investors have adopted a bearish approach towards Bank of America (NYSE: BAC), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BAC usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 27 extraordinary options activities for Bank ...

Whales with a lot of money to spend have taken a noticeably bullish stance on FedEx.Looking at options history for FedEx (NYSE: FDX) we detected 8 trades.If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 0% with bearish.From the overall spotted trades, 2 are puts, for a total amount of $77,259 and 6, calls, for a total amount of $200,426.Projected Price TargetsTaking into account the Volume and Open Interest on these con ...

Deep-pocketed investors have adopted a bullish approach towards Micron Technology (NASDAQ: MU), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MU usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 89 extraordinary options activities for Mi ...

Looking into the current session, DuPont de Nemours Inc. (NYSE: DD) shares are trading at $76.89, after a 0.93% spike. Moreover, over the past month, the stock went up by 1.45%, but in the past year, decreased by 12.55%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. Evaluating DuPont de Nemours P/E in Comparison to Its PeersThe P/E ratio measures the current share price to the company's EPS. It is used by lon ...

Innoviz Technologies’ (NASDAQ: INVZ) stock jumped 15% Monday as investors bet on new design wins and growth in autonomous driving.INVZ shares are powering higher on strong volume. See the market dynamics here.Shares gained despite the company trading at a discount to lidar peers, with optimism fueled by potential major automaker deals.Goldman Sachs analyst Mark Delaney upgraded the stock rating from Neutral to Buy and raised its price target from $1.50 to $2.50.Also Read: Innoviz Technologies Secures LiDAR ...

Wall Street kicked off the week with modest gains in technology and growth names, while small caps and blue chips stalled as investors braced for a flood of economic data, culminating on Friday with the September labor market report. Washington politics also drew attention, with President Donald Trump set to meet Democratic and Republican leaders later today in an effort to head off a potential government shutdown as early as Wednesday.The S&P 500 edged 0.3% higher to 6,660, while the Nasdaq 100 advanced 0. ...